1. Home
  2. WS vs ANIP Comparison

WS vs ANIP Comparison

Compare WS & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worthington Steel Inc.

WS

Worthington Steel Inc.

HOLD

Current Price

$33.16

Market Cap

1.8B

Sector

N/A

ML Signal

HOLD

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$77.40

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WS
ANIP
Founded
1955
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
2023
1999

Fundamental Metrics

Financial Performance
Metric
WS
ANIP
Price
$33.16
$77.40
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$42.50
$110.00
AVG Volume (30 Days)
231.1K
337.0K
Earning Date
03-25-2026
05-08-2026
Dividend Yield
1.76%
N/A
EPS Growth
N/A
419.23
EPS
0.17
2.32
Revenue
$3,443,800,000.00
$206,547,000.00
Revenue This Year
$16.77
$21.01
Revenue Next Year
$2.69
$17.59
P/E Ratio
$198.59
$32.50
Revenue Growth
11.33
2.47
52 Week Low
$27.22
$69.58
52 Week High
$49.17
$97.52

Technical Indicators

Market Signals
Indicator
WS
ANIP
Relative Strength Index (RSI) 41.06 57.28
Support Level $31.20 $75.94
Resistance Level $35.42 $83.20
Average True Range (ATR) 1.27 1.86
MACD -0.12 0.69
Stochastic Oscillator 21.04 91.85

Price Performance

Historical Comparison
WS
ANIP

About WS Worthington Steel Inc.

Worthington Steel Inc is a processor of carbon flat-rolled steel, a producer of laser-welded solutions, and a provider of electrical steel laminations. The company has manufacturing facilities across the United States, Canada, China, India, Germany and Mexico. It buys coils of steel from primary steel producers and processes them to precise type, thickness, length, width, shape, and surface quality required by customer specifications. The company's product lines and processing capabilities include; carbon flat-rolled steel processing, electrical steel laminations, and tailor welded products. Geographically, the company generates a majority of its revenue from the United States followed by Canada, Mexico, and other regions.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: